Jak Knowles

Dr. Jak Knowles serves as Metagenomi’s Chief Business Officer starting in October, 2020. Prior to joining Metagenomi, Jak was VP of Venture Investments at Leaps by Bayer where he helped lead Metagenomi’s initial seed financing and early strategy serving on Metagenomi’s Board of Directors. Prior to joining Bayer, Jak served as CEO of CytoSen Therapeutics, where he worked to develop Natural Killer cell immunotherapies for oncology indications. In 2016, Jak co-founded and launched Exonics Therapeutics, a CRISPR gene-editing company, serving as President and interim-CEO. Jak has a medical degree from Stanford University where he graduated with honors in biomedical research. Jak previously served on the Board of Directors for Century Therapeutics, Triumvira Immunologics, Pyxis Oncology, Vesigen Therapeutics, and Metagenomi Technologies.